Savic Maja, Dragasevic Nevena, Sretenovic Jasmina, Mihajlovic Katarina, Andjic Marijana, Djordjevic Katarina, Pindovic Bozidar, Zivkovic Vladimir, Srejovic Ivan, Bolevich Sergey, Bolevich Stefani, Jakovljevic Vladimir, Nikolic Turnic Tamara
Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, 34000, Kragujevac, Serbia.
Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, 34000, Kragujevac, Serbia.
Mol Cell Biochem. 2025 Jun;480(6):3695-3708. doi: 10.1007/s11010-024-05203-w. Epub 2025 Jan 12.
As several decades of research have shown the cardioprotective effects of angiotensin-converting enzyme (ACE) inhibitors alone or in combination with diuretics, we were interested in investigating the effects of subchronic therapy of these drugs on ischemia-reperfusion (I/R) damage to the heart, as well as their influence on oxidative status. The research was conducted on 40 spontaneously hypertensive male Wistar Kyoto rats, divided into 4 groups. Animals were treated for four weeks with 10 mg/kg/day zofenopril alone or in combination with hydrochlorothiazide, indapamide and spironolactone per os. After the treatment, hemodynamic measurements, echocardiography and assessment of myocardial function were performed according to Langendorff's retrograde perfusion method. The induced global ischemia model involved 20 min of ischemia followed by 30 min of reperfusion to the heart (I20:R30). Markers of oxidative stress were determined spectrophotometrically from plasma and erythrocyte lysates. Heart and kidney tissue samples were pathohistologically analyzed. Treatment with a combination of ACE inhibitors and diuretics significantly lowered blood pressure in spontaneously hypertensive rats, alleviated left ventricular hypertrophy and increased ejection fraction. On the other hand, treatment with zofenopril and diuretics showed pro-oxidative potential. Pathohistological analysis of heart and kidney tissue samples indicates that subchronic administration of antihypertensive agents does not lead to significant changes in these organs. Since the antihypertensive therapy was relatively short (only 4 weeks), in order to elucidate or deny the prooxidative mechanism, additional studies of a longer time interval are needed and planned.
几十年来的研究表明,血管紧张素转换酶(ACE)抑制剂单独使用或与利尿剂联合使用具有心脏保护作用,因此我们有兴趣研究这些药物的亚慢性治疗对心脏缺血再灌注(I/R)损伤的影响,以及它们对氧化状态的影响。该研究以40只自发性高血压雄性Wistar Kyoto大鼠为对象,分为4组。动物口服10mg/kg/天的佐芬普利单独或与氢氯噻嗪、吲达帕胺和螺内酯联合治疗四周。治疗后,根据Langendorff逆行灌注法进行血流动力学测量、超声心动图检查和心肌功能评估。诱导的全脑缺血模型包括心脏缺血20分钟,然后再灌注30分钟(I20:R30)。通过分光光度法测定血浆和红细胞裂解物中的氧化应激标志物。对心脏和肾脏组织样本进行病理组织学分析。ACE抑制剂和利尿剂联合治疗可显著降低自发性高血压大鼠的血压,减轻左心室肥厚并提高射血分数。另一方面,佐芬普利和利尿剂治疗显示出促氧化潜力。心脏和肾脏组织样本的病理组织学分析表明,亚慢性给予抗高血压药物不会导致这些器官发生显著变化。由于抗高血压治疗时间相对较短(仅4周),为了阐明或否定促氧化机制,需要并计划进行更长时间间隔的额外研究。